Adan Medical Innovation

Adan Medical Innovation is a company focused on the improvement of the quality of life of patients that suffer from anaphylaxis, a severe allergic reaction. To achieve this, we have formed a group of experts in different fields (physicians specialized in Allergy and Internal Medicine, business development, patent and regulatory health technologies issues, engineers, information technologies), even including patients among us, and we are working together to offer the best solutions for these patients. The company has developed integrated digital solutions to improve the management of anaphylaxis, having nowadays two different products in its pipeline: AnAPPhylaxis, a smart case for epinephrine auto-injectors connected to a mobile App, and WE SAVE, a smart box of epinephrine auto-injectors for public spaces. Our main product, AnAPPhylaxis, has been recently tested by a clinical trial performed at Vall d'Hebrón Hospital, proving the satisfaction and effectiveness of this medical device. Among other features, it monitors epinephrine's quality, alerts when auto-injector is forgotten and executes an automated emergency protocol when used, making patient's life easier. The company has received several grants and endorsement from key opinion leaders in the field, that encourage us to be in constant growing. To learn more: http://www.adanmi.com/ or https://capitalcell.es/campaign/anapphylaxis/.

• Employees 4
• Founded 2014
• Total Funding $1294474